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Abstract 
Background: Plasmodium falciparum in pregnancy results in substantial poor health outcomes for both mother and 
child, particularly in young, primigravid mothers who are at greatest risk of placental malaria (PM) infection. Compli‑
cations of PM include maternal anaemia, low birth weight and preterm delivery, which contribute to maternal and 
infant morbidity and mortality in coastal Papua New Guinea (PNG).
Methods: Placental biopsies were examined from 1451 pregnant women who were enrolled in a malaria prevention 
study at 14–26 weeks gestation. Clinical and demographic information were collected at first antenatal clinic visits 
and women were followed until delivery. Placental biopsies were collected and examined for PM using histology. The 
presence of infected erythrocytes and/or the malaria pigment in monocytes or fibrin was used to determine the type 
of placental infection.
Results: Of 1451 placentas examined, PM infection was detected in 269 (18.5%), of which 54 (3.7%) were acute, 55 
(3.8%) chronic, and 160 (11.0%) were past infections. Risk factors for PM included residing in rural areas (adjusted odds 
ratio (AOR) 3.65, 95% CI 1.76–7.51; p ≤ 0.001), being primigravid (AOR 2.45, 95% CI 1.26–4.77; p = 0.008) and hav‑
ing symptomatic malaria during pregnancy (AOR 2.05, 95% CI 1.16–3.62; p = 0.013). After adjustment for covariates, 
compared to uninfected women, acute infections (AOR 1.97, 95% CI 0.98–3.95; p = 0.056) were associated with low 
birth weight babies, whereas chronic infections were associated with preterm delivery (AOR 3.92, 95% CI 1.64–9.38; 
p = 0.002) and anaemia (AOR 2.22, 95% CI 1.02–4.84; p = 0.045).
Conclusions: Among pregnant PNG women receiving at least one dose of intermittent preventive treatment in 
pregnancy and using insecticide‑treated bed nets, active PM infections were associated with adverse outcomes. 
Improved malaria prevention is required to optimize pregnancy outcomes.
Keywords: Placental malaria, Pregnancy, Birth outcomes, Intermittent preventive treatment in pregnancy, 
Insecticide‑treated bed nets, Papua New Guinea
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Background
In endemic areas, malaria in pregnancy poses a substan-
tial risk for both mother and child. Globally, over 125 
million pregnant women are at risk of malaria infection 
[1] and up to 200,000 infant deaths and 10,000 maternal 
deaths occur annually due to malaria in pregnancy [2–4].
In African settings, pregnant women are more vul-
nerable to malaria infection than non-pregnant women 
[4] and susceptibility is highest in young, primigravid 
mothers who have two to seven times higher risk of 
delivering low birth weight (LBW, < 2500 g) babies than 
multigravidae [2], while other associated poor out-
comes include maternal anaemia and preterm delivery 
(PTD, < 37 weeks) [2, 4]. There are relatively limited data 
from Papua New Guinea (PNG), although previous stud-
ies have reported similar findings [5–7]. Both LBW and 
PTD complicating malaria in pregnancy are associated 
with increased risk of infant mortality [4] and high rates 
of cognitive impairment, learning disability and behav-
ioural problems in children [2]. Maternal anaemia due to 
malaria is an independent risk factor for LBW and intra-
uterine growth restriction (IUGR) [8–10] and may also 
increase the risk of PTD and stillbirth [5, 11].
The presence of infected erythrocytes (IE) or malaria 
pigment (haemozoin) in the intervillous spaces of pla-
centa is termed placental malaria (PM) [8, 12, 13]. The 
mature asexual stages of Plasmodium falciparum IE can 
sequester in the placenta [10] and avoid splenic clear-
ance. Often pregnant women are asymptomatic, and the 
absence of detectable peripheral parasitaemia does not 
preclude placental infection [8, 14, 15] making detection 
and treatment challenging [16, 17]. Methods to detect P. 
falciparum in pregnancy include peripheral and placen-
tal blood microscopy, antigen detection tests, polymer-
ase chain reaction (PCR) and placental histology [16]. Of 
these, placental histology [18, 19] and PCR are the most 
sensitive techniques [16, 17].
In previous studies, placental IE and macrophages con-
taining malaria pigment detected on placental histology 
have been associated with decreased infant birth weight 
and maternal haemoglobin concentration [19]. In stud-
ies of sub-microscopic infections detected by PCR, these 
infections were associated with anaemia but less com-
monly with LBW [18, 20]. Women with malaria detected 
by microscopy were more likely to be anaemic and had 
lower haemoglobin concentrations than uninfected 
women [18, 19].
Malaria is hyperendemic with perennial malaria trans-
mission in coastal areas of PNG, reaching levels rarely 
found outside of sub-Saharan Africa [21] and it contrib-
utes significantly to maternal mortality and LBW [6, 22]. 
In this setting, malaria has been associated with LBW due 
to both IUGR and PTD (which has also been associated 
with maternal anaemia) and these adverse outcomes are 
particularly common in primigravid women [5, 7, 22]. 
Since these earlier studies, there have been changes to 
malaria control programs during pregnancy. To inves-
tigate this further, the prevalence of PM, risk factors for 
PM, and maternal anaemia and birth outcomes associ-
ated with PM were studied in a cohort of women receiv-
ing at least one dose of intermittent preventive treatment 
in pregnancy (IPTp) and sleeping under insecticide-
treated bed nets (ITN).
Methods
Study population and design
The study was conducted in Madang Province located on 
the north coast of PNG. Following written informed con-
sent, pregnant women aged 16–49 years and between 14 
and 26 weeks gestation (by fundal height) were recruited 
into a randomized clinical trial comparing three doses of 
IPTp with sulfadoxine/pyrimethamine (SP, 1500/75  mg) 
and azithromycin (AZ, 1 g twice daily for 2 days) as com-
pared to a curative dose of SP and chloroquine (CQ) [22]. 
Women were excluded if they had tuberculosis, diabe-
tes, renal failure, severe anaemia (haemoglobin  <  7  g/
dL), permanent disability or multiple pregnancies. The 
study protocol was approved by PNG Institute of Medical 
Research (IMR) Institutional Review Board (0815), PNG 
Medical Research Advisory Committee (08.01) and Mel-
bourne Health Human Research Ethics Committee, Aus-
tralia (2008.162). The clinical trial registration number is 
NCT01136850 [22].
Clinical data collection
Basic clinical and demographic data were collected at first 
antenatal clinic (ANC) visit and haemoglobin concentra-
tion was measured by  HemoCue® device (HemoCue, 
Ångelholm, Sweden). At delivery additional clinical data 
were collected, birth weight was measured using a digi-
tal baby scale (Cupid 1, Charder Medical, Taiwan) shortly 
after delivery, and maternal haemoglobin was measured 
again. Anaemia was defined as maternal haemoglo-
bin < 11.0 g/dL, and categorized as mild (Hb 9.0–10.9 g/
dL), moderate (7.0–8.9  g/dL) and severe (<  7.0  g/dL). 
Symptomatic women with a positive malaria rapid diag-
nostic test (CareStart™ P.f/Pan combo, Access-Bio, USA) 
at ANC visits were considered to have clinical malaria 
and were treated with anti-malarials. PTD was defined 
based on obstetric ultrasound, performed in a subset of 
participants, using the earliest available dating scan.
Plasmodium species diagnosis
Peripheral thick and thin blood slides collected at enrol-
ment, follow-up visits and delivery were Giemsa-stained 
and examined for malaria parasite speciation and density 
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quantification using established methods [23]. Those 
blood slides positive for malaria were not treated with 
anti-malarials.
Placental biopsy collection, preparation and processing
Placental biopsies were collected from the maternal side 
of the placenta. Incisions extended from the maternal to 
the fetal side of the placenta without reaching the fetal 
membrane. Biopsies were fixed and transported in 10% 
neutral buffered formalin for processing at the Univer-
sity of Melbourne Histology Department. Sections were 
stained with Giemsa, cover slipped and returned to PNG 
for analyses. A subset of placental biopsies was examined 
in Barcelona, Spain for quality control.
Placental histology evaluation
The histological analysis was performed primarily in 
Madang, PNG, where examiners were blinded to inter-
vention group and clinical data. Each placental slide 
was classified for malaria infection using the presence 
or absence of three histological features: IE, malaria pig-
ment in monocytes/macrophages, and malaria pigment 
in fibrin deposits [24, 25] (Table 1). All cases with para-
sites (acute and chronic infections) were termed active 
infections [24], and for analysis we combined both active 
and past infections, due to the relatively small number of 
the former.
Data analysis
The placental histology data were merged with the exist-
ing clinical database, and correlated with clinical and 
demographic variables using the Pearson Chi squared 
test for categorical variables, and the Student’s t test for 
normally distributed continuous variables between two 
groups. Logistic and linear regression analyses were per-
formed to identify risk factors and adverse maternal and 
infant outcomes associated with PM at delivery. Univari-
able associations were determined between clinical and 
demographic risk factors for PM and gestational age, 
anaemia, haemoglobin concentration, birth weight, LBW 
and PTD. Predictors of infant and maternal outcomes 
were identified from adjusted regression models includ-
ing all exposure variables. All tests were two-tailed and 
the confidence level was set at 95%. All statistical analyses 
were performed using Stata 11 (Stata Corp, Texas, USA).
Results
Clinical and demographic characteristics of study cohort
A total of 1451 pregnant women with placental biopsies 
including their matched clinical and laboratory data were 
available for inclusion in this study (Fig. 1). Their demo-
graphical and clinical characteristics are summarized in 
Table 2. The study population included equal proportions 
of women from both trial arms, and 11.9% (172/1448) 
experienced symptomatic malaria during their pregnancy 
(Table  2). The mean age was 24  ±  5.4  years and mean 
body weight was 54  ±  9.7  kg (Table  2). Approximately 
half (50.9%, 738/1449) of the women were primigravid, 
and 26.7% (379/1420) were defined as malnourished 
with a mid-upper arm circumference (MUAC) < 23 cm. 
Most women were of coastal ethnicities and the major-
ity resided in rural areas. They were generally subsistence 
farmers or earning wages and equal proportions of them 
used bed nets with or without insecticides (Table 2).
Prevalence of placental malaria infection
Placental biopsies for histological examination and deliv-
ery data were available from 1451 pregnant women. Of 
1451 placentas examined, 18.5% (269/1451) showed 
evidence of current or past PM. There were 7.5% active 
infections [3.7% (54/1451) acute, and 3.8% (55/1451) 
chronic], and 11.0% (160/1451) past infections.
Risk factors for placental malaria infection at delivery
In univariate analyses, women’s weight (OR 0.98, 95% CI 
0.97–1.00; p =  0.014), and age (OR 0.96, 95% CI 0.93–
0.98; p  =  0.001), were negatively associated with PM, 
while first pregnancy increased the likelihood of PM (OR 
1.73, 95% CI 1.24–2.40; p = 0.001) (Table 3). Risk factors 
for PM included living in rural (OR 3.09, 95% CI 1.95–
4.88; p  ≤  0.001) or peri-urban areas (OR 1.76, 95% CI 
1.02–3.02; p = 0.041), having recently migrated into the 
study area from other provinces of PNG (OR 2.59, 95% 
CI 1.27–5.26; p =  0.009), using bed nets without insec-
ticides (OR 1.42, 95% CI 1.04–1.92; p = 0.025), and pre-
senting with clinical malaria (OR 1.56, 95% CI 1.07–2.26; 
p  =  0.020) (Table  3). In multivariate analyses, clinical 
malaria (AOR 2.05, 95% CI 1.16–3.62; p  =  0.013), first 
pregnancy (AOR 2.45, 95% CI 1.26–4.77; p = 0.008) and 
rural residence (AOR 3.65, 95% CI 1.76–7.51; p ≤ 0.001) 
remained significant risk factors for PM (Table 3).
Association of placental malaria with maternal anaemia, 
low birth weight, and preterm delivery at birth
Anaemia was highly prevalent in this population 
(72.6%, 961/1323). In unadjusted analyses, women 
Table 1 Classification of placental pathology [24, 25]
Infection stages Description
Acute Parasites, no pigment in monocytes or fibrin
Chronic Parasites, pigment in monocytes and/or fibrin
Past No parasites, pigment only
No No parasites or pigment
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with chronic (p  ≤  0.001) and past (p  =  0.023) infec-
tions had lower haemoglobin concentrations than 
uninfected women. In adjusted analyses, only chronic 
infection remained associated with reduced haemo-
globin concentrations (Table  4). In unadjusted analy-
ses, women with chronic (OR 2.13, 95% CI 0.99–4.58; 
p  =  0.053) and past (OR 1.64, 95% CI 1.06–2.53; 
p = 0.025) infections were at two fold increased odds 
of having anaemia compared to uninfected women. In 
adjusted analyses, only chronic infections remained 
associated with anaemia (AOR 2.22, 95% CI 1.02–4.84; 
p = 0.045) (Table 4).
2793 women enrolled into IPTp trial
Trial protocol deviation: 73
2720 women enrolled into sub-study
2231 women with pregnancy outcome information
Miscarriage: 6
Twins: 4
No histology collected (missed, late presentation): 766
Incomplete sample or clinical data: 4
1451 women included in analyses
Withdrawn from trial before delivery: 43
Lost to follow-up for pregnancy outcome: 446
Fig. 1 Flowchart showing the number of pregnant women enrolled for the parent study whose placental histology was collected for placental 
malaria investigation
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The severity of anaemia was significantly associated 
with PM stages. Among women with chronic PM, more 
had moderate anaemia (35.3%, 18/51) and severe anae-
mia (11.8%, 6/51) compared to uninfected women (mod-
erate anaemia 14.9%, 161/1079 and severe anaemia 3.2%, 
34/1079) (p ≤ 0.001), respectively.
Low birth weight was prevalent in this study cohort 
(14.0%, 203/1448). In unadjusted analyses, there were 
significant associations between presence of acute 
(p = 0.005), chronic (p = 0.042) or past (p = 0.002) PM 
infections and reduced birth weight, while only acute PM 
infections (OR 1.95, 95% CI 1.00–3.80; p =  0.049) were 
associated with increased odds to have LBW babies. In 
adjusted analyses, acute PM infections were associ-
ated with reduced birth weight compared to uninfected 
women, and with increased risk of LBW deliveries (AOR 
1.97, 95% CI 0.89–3.95; p  =  0.056) compared to unin-
fected women (Table  4). Women with acute infections 
(mean birth weight, 2780 ± 692 g; p = 0.002) had birth 
weights on average 199 g lower than uninfected women 
(mean birth weight, 2979 ± 490 g).
Preterm delivery determined by ultrasound dating 
was observed in 8.4% (81/962) of women in this study. 
The timing of the ultrasound dating was compared by 
groups with different placental histology findings. There 
were no significant differences in timing of first ultra-
sound between groups, women with chronic PM infec-
tions were almost four times more likely to have PTD 
compared to uninfected women (AOR 3.92, 95% CI 
1.64–9.38; p = 0.002) (Table 4). Women with acute PM 
infections (AOR 2.33, 95% CI 0.86–6.35; p = 0.097) also 
had increased odds to have PTD but the association 
was not statistically significant (Table  4). When dura-
tion of gestation was examined, women with chronic PM 
infections (mean gestational age, 271 ± 13 days) had an 
average gestational age approximately 4  days less than 
those with no PM (mean gestational age; 275 ± 13 days; 
p = 0.041).
Discussion
In the context of a trial of IPTp in PNG [22], the preva-
lence and risk factors for PM infection are examined, 
and poor pregnancy outcomes associated with PM are 
described. In the largest survey of PM in Western Pacific 
region to date, risk factors for PM include residing in 
rural areas, being primigravid and having symptomatic 
malaria infection during pregnancy. The impact of PM on 
pregnancy outcomes varied according to the type of pla-
cental infection. Maternal anaemia and PTD were associ-
ated with chronic PM infections, whereas LBW was more 
common in acute PM infections.
The present study focused on P. falciparum-infected 
placentas, as this parasite was the only one detected in 
placentas with active infection by qPCR, and it is the 
major cause of adverse effects on the mother and baby 
world-wide in regions where malaria is endemic [1]. Pre-
vious studies in the same area showed high prevalence 
of P. falciparum malaria in pregnant women [6, 26] with 
PM detected in over 40% of pregnancies [7, 27]. In the 
Table 2 Clinical and  demographic characteristics of  preg-
nant women with and without placental malaria
Data are number (%), or mean [standard deviation]
IPTp intermittent preventive treatment in pregnancy, MUAC mid-upper arm 
circumference, ITN insecticide-treated bed nets
† Estimated by Pearson Chi squared and ♦ Student t tests, p values are shown. 
p < 0.05 marked in italic
Risk factors n Placental malaria p†
Maternal Positive Negative
IPTp
 Intervention arm 726/1451 126 (46.8) 600 (50.8) 0.246
 Control arm 725/1451 143 (53.2) 582 (49.2)
Clinical malaria 172/1448 43 (25.0) 129 (75.0) 0.020
MUAC (cm) 379/1420 78 (20.6) 301 (79.4) 0.212
Weight (kg) 54.3 [± 9.7] 53 [± 8.0] 55 [± 10.0] 0.007♦
Age (years) 24.5 [± 5.4] 23 [± 5.0] 25 [± 5.5] 0.003♦
Gravidity
 Primigravidae 738/1449 164 (61.0) 574 (48.6) 0.001
 Secundigravidae 309/1449 48 (17.8) 261 (22.2)
 Multigravidae 402/1449 57 (21.2) 345 (29.2)
Ethnic group
 Sepik 258/1450 46 (17.1) 212 (82.2) 0.025
 Madang/morobe 934/1450 190 (70.6) 744 (79.7)
 Highlands 125/1450 12 (4.5) 113 (90.4)
 Other 133/1450 21 (7.8) 112 (84.2)
Place of residence
 Rural 827/1445 190 (70.6) 637 (77.0) ≤ 0.001
 Peri‑urban 282/1445 41 (15.2) 241 (20.5)
 Migrant 75/1445 15 (5.6) 60 (5.1)
 Urban 261/1445 23 (8.6) 238 (20.2)
Bednet use
 Not used 328/1445 57 (21.3) 271 (23.0) 0.064
 Used, not ITN 600/1445 128 (47.8) 472 (40.1)
 Used, ITN 517/1445 83 (30.9) 434 (36.9)
Socio‑economic
 Employment
  Subsistence 
farmer
313/745 62 (42.2) 251 (41.9) 0.700
  Self‑employed 149/745 26 (17.7) 123 (20.6)
  Wage earner 283/745 59 (40.1) 224 (37.5)
Literate 1371/1450 257 (18.8) 1114 (81.2) 0.429
Betel nut chewer 1198/1444 221 (18.5) 977 (81.5) 0.926
Smoker 282/1450 45 (16.0) 237 (84.0) 0.212
Alcohol consumer 83/1446 9 (10.8) 74 (89.2) 0.063
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present study, PM was found in 18.5% of participants, 
and past infections were most prevalent. As previously 
reported, the prevalence of acute or chronic PM was 
lower in women who received SP and AZ [22], suggesting 
this combination offered protection against active PM, 
although it was not associated with reductions in past 
infection. The lower prevalence of PM infection com-
pared to previous studies may reflect the recent overall 
decline of malaria in PNG [28].
The risk factors associated with PM infections vary 
between different epidemiological settings where malaria 
is endemic. In the present study, symptomatic malaria 
illness during pregnancy, being in first pregnancy, 
and residing in rural areas were risk factors for PM in 
adjusted analyses. While malaria infections are often 
asymptomatic during pregnancy, a significant proportion 
of parasitaemic women have symptoms such as fever, 
headache, malaise and dizziness [29]; the data suggest 
Table 3 Univariate and multivariate analyses for risk factors associated with placental malaria
Data are odds ratios (95% confident interval) for logistic regression models, p values are shown. p < 0.05 marked in italic
IPTp intermittent preventive treatment in pregnancy, MUAC mid-upper arm circumference, ITN insecticide-treated bed nets, REF reference group
a Multivariate analyses included all risk factors
Risk factors n Unadjusted (95% CI) p Adjusted (95% CI)a p
Maternal
IPTp, n = 1451
 Intervention arm 726 0.85 (0.66–1.11) 0.246 0.69 (0.47–1.03) 0.068
 Control arm 725 REF REF REF REF
Clinical malaria, n = 1448 172 1.56 (1.07–2.26) 0.020 2.05 (1.16–3.62) 0.013
MUAC (cm), n = 1420 379 1.21 (0.90–1.62) 0.212 1.04 (0.65–1.66) 0.881
Weight (kg) 1451 0.98 (0.97–1.00) 0.014 0.98 (0.96–1.00) 0.080
Age (years) 1451 0.96 (0.93–0.98) 0.001 1.00 (0.95–1.05) 0.979
Gravidity, n = 1449
 Primigravidae 738 1.73 (1.24–2.40) 0.001 2.45 (1.26–4.77) 0.008
 Secundigravidae 309 1.11 (0.73–1.69) 0.614 1.40 (0.70–2.78) 0.344
 Multigravidae 402 REF REF REF REF
Ethnic group, n = 1450
 Sepik 258 1.16 (0.66–2.04) 0.612 1.06 (0.46–2.47) 0.892
 Madang/morobe 934 1.36 (0.83–2.23) 0.219 0.92 (0.45–1.89) 0.825
 Highlands 125 0.57 (0.27–1.21) 0.140 0.60 (1.81–2.00) 0.409
 Other 133 REF REF REF REF
Place of residence, n = 1445
 Rural 827 3.09 (1.95–4.88) ≤ 0.001 3.65 (1.76–7.51) ≤ 0.001
 Peri‑urban 282 1.76 (1.02–3.02) 0.041 1.32 (0.55–3.17) 0.451
 Migrant 75 2.59 (1.27–5.26) 0.009 1.65 (0.50–5.37) 0.409
 Urban 261 REF REF REF REF
Bednet use, n = 1445
 Not used 328 1.10 (0.76–1.59) 0.614 1.26 (0.73–2.16) 0.402
 Used, not ITN 600 1.42 (1.04–1.92) 0.025 1.43 (0.91–2.24) 0.123
 Used, ITN 517 REF REF REF REF
Socio‑economic
 Employment, n = 745
  Subsistence farmer 313 0.94 (0.63–1.40) 0.753 0.64 (0.40–1.03) 0.064
  Self‑employed 149 0.80 (0.48–1.34) 0.399 0.83 (0.47–1.47) 0.523
  Wage earner 283 REF REF REF REF
 Literate, n = 1450 1371 1.29 (0.69–2.42) 0.430 0.84 (0.34–2.10) 0.708
 Betel nut chewer, n = 1444 1198 0.98 (0.69–1.40) 0.926 1.67 (0.89–3.13) 0.107
 Smoker, n = 1450 282 0.80 (0.56–1.14) 0.212 0.96 (0.57–1.62) 0.874
 Alcohol consumer, n = 1446 83 0.52 (0.26–1.05) 0.068 0.35 (0.11–1.07) 0.065
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these symptomatic infections might be a proxy for PM 
infection, especially in light of changing epidemiology of 
malaria [30].
In this cohort, primigravid women were most suscepti-
ble to PM infection, and this susceptibility decreased with 
subsequent pregnancy, as commonly observed elsewhere 
[2]. It is generally understood that primigravid women 
are uniquely susceptible because they lack pregnancy-
specific malaria immunity in the form of antibodies and 
memory B cells to the pregnancy-specific parasite variant 
surface antigen VAR2CSA [3]. These protective antibody 
responses develop over subsequent pregnancies, confer-
ring protection against PM [31].
Furthermore, the vulnerability of pregnant women to 
PM infection is also increased by extrinsic factors during 
pregnancy. Women in the present cohort who were liv-
ing in rural areas had a higher risk of PM infection. The 
spatial variation in PM infection risk amongst the women 
residing at various localities may be due to the heteroge-
neous transmission of malaria in this area, and previous 
studies have confirmed higher rates of transmission in 
rural settings where the main vector Anopheles punctu-
latus group of mosquitoes are predominantly found com-
pared to urban areas [21].
Anaemia was highly prevalent in this cohort, and there 
were associations between anaemia or lower haemoglo-
bin concentrations and PM. Chronic PM infection was 
associated with a significant reduction in maternal hae-
moglobin concentration, and it was also associated with 
increased risk of anaemia in adjusted analyses, in keeping 
with studies from Africa [25, 32]. Women with chronic 
PM were at significantly increased risk of moderate and 
severe anaemia compared to those with no PM infec-
tions. Although anaemia was associated with PM infec-
tions, there may be other factors that have contributed to 
anaemia in the present cohort, such as iron and/or folate 
deficiency [33], splenomegaly, red blood cell genetic traits 
such as alpha thalassaemia, and hookworm infection, all 
of which are prevalent in this setting [5, 7, 34, 35].
This study is consistent with previous findings [36] 
demonstrating P. falciparum acute PM infections were 
significantly associated with reduced mean birth weight, 
which may predispose to greater risk of morbidity and 
mortality in infancy [12, 25]. Although previous studies 
from this setting had reported that chronic PM infec-
tion was associated with LBW [7, 37], acute PM infec-
tions were particularly associated with LBW in the 
current study. This difference may be due to different 
study design. In the current study, women received ITNs 
and between one and three courses of IPTp, whereas 
previous studies were observational in nature, chloro-
quine prophylaxis rather than IPTp was recommended 
but not supervised and women were not provided with 
ITNs, potentially predisposing to longer duration chronic 
infections. In keeping with this, in an observational study 
African pregnant women, chronic PM infection espe-
cially with massive chronic intervillositis (the accumula-
tion of large number of white blood cells in the maternal 
intervillous space of placenta) was associated with LBW 
while acute PM infection with high parasitaemia was 
associated with PTD [32]. Other factors may be contrib-
uting significantly to reduced fetal growth. Most women 
in the present study were anaemic and the occurrence 
of anaemia may have had a direct effect on fetal growth 
[35]. Additionally, less than 30% of the cohort was mal-
nourished, suggesting that these women could have poor 
nutritional status. A previous study in the same setting 
reported associations between poor maternal nutritional 
status and reduced infants’ birth weight [5].
In this cohort, chronic PM infection was associated 
with increased risk of PTD. PM infection may contrib-
ute to LBW via multiple mechanisms including IUGR or 
PTD [38]. Although the causes of IUGR and PTD differ, 
this study supports the notion that PM infection may be 
an underlying cause of both in this population, alongside 
other factors. In this study, 24.1 and 28.4% of all LBW 
and PTD, respectively, were associated with PM. A previ-
ous study in this setting had reported that PM infection 
was associated with LBW mostly caused by IUGR rather 
than PTD; however, the latter was associated with mater-
nal anaemia [5, 22].
There are some potential limitations to the present 
study. First, the pregnant women enrolled in the study 
might not be a true representation of population in the 
region since most women attended ANC at advanced 
gestational age and were ineligible to join the study [22]. 
Second, the health facilities used for the recruitment of 
study participants were in close proximity to the urban 
centre, therefore the study may not have measured the 
full extent of malaria in distant rural settings. Third, due 
to sampling and technical issues placental tissues from 
over 500 women who completed the clinical study were 
not able to be assessed. Although both P. falciparum and 
Plasmodium vivax are endemic in PNG [6], and P. vivax 
PM infection had been reported [39], the study might 
have underestimated the possibility that P. vivax can 
sequester in placenta even though the mechanism is less 
well understood [11]. Despite this, the study remains the 
largest to assess for the prevalence of PM, geographic 
and clinical risk factors including adverse pregnancy out-
comes associated with PM in the Western Pacific region.
Conclusions
The prevalence of PM infection in Madang has declined 
in the last decade, probably reflecting changes in malaria 
transmission reported across the country. Women with 
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symptomatic malaria during pregnancy, primigravidae, 
and women who lived in rural settings were at increased 
risk for PM, despite receiving one dose of malaria proph-
ylaxis and sleeping under insecticide-treated bed nets. 
Chronic PM infections were associated with anaemia, 
which was highly prevalent in the study cohort; acute PM 
infections were associated with a doubling of the likeli-
hood of LBW; and chronic PM infections were associated 
with substantially increased likelihood of PTD. Associa-
tions between different categories of PM and adverse out-
comes indicate that there is still need for health policy 
makers to improve the access and uptake of available pre-
ventive measures to prevent malaria in pregnancy in PNG.
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